Abstract: The present invention addresses the problem of providing: a compound, or a salt thereof, which constitutes a lipid composition that can realize a high nucleic acid encapsulation rate and excellent nucleic acid delivery when mRNA is used; and a lipid composition, a pharmaceutical composition, and a delivery carrier that can realize a high nucleic acid encapsulation rate and excellent nucleic acid delivery when mRNA is used. The present invention provides a compound represented by formula (1), or a salt thereof. In the formula, R1 represents a hydrocarbon group having 1-24 carbon atoms; R2 represents a hydrocarbon group having 1-6 carbon atoms, R3 represents a hydrocarbon group having 6-24 carbon atoms and having a branched chain; R4 and R5 each represents a hydrocarbon group having 1-6 carbon atoms which are optionally substituted; R6 represents a hydrogen atom or a hydrocarbon group having 1-18 carbon atoms; L represents *-O-C(O)- or *-C(O)O -; a represents an integer of 1-12; and b, c, and d each represents an integer of 1-4.
| # | Name | Date |
|---|---|---|
| 1 | 202547085449-STATEMENT OF UNDERTAKING (FORM 3) [09-09-2025(online)].pdf | 2025-09-09 |
| 2 | 202547085449-REQUEST FOR EXAMINATION (FORM-18) [09-09-2025(online)].pdf | 2025-09-09 |
| 3 | 202547085449-PROOF OF RIGHT [09-09-2025(online)].pdf | 2025-09-09 |
| 4 | 202547085449-PRIORITY DOCUMENTS [09-09-2025(online)].pdf | 2025-09-09 |
| 5 | 202547085449-FORM 18 [09-09-2025(online)].pdf | 2025-09-09 |
| 6 | 202547085449-FORM 1 [09-09-2025(online)].pdf | 2025-09-09 |
| 7 | 202547085449-DRAWINGS [09-09-2025(online)].pdf | 2025-09-09 |
| 8 | 202547085449-DECLARATION OF INVENTORSHIP (FORM 5) [09-09-2025(online)].pdf | 2025-09-09 |
| 9 | 202547085449-COMPLETE SPECIFICATION [09-09-2025(online)].pdf | 2025-09-09 |
| 10 | 202547085449-FORM-26 [10-09-2025(online)].pdf | 2025-09-10 |
| 11 | 202547085449-Proof of Right [12-09-2025(online)].pdf | 2025-09-12 |